Compound Detail
CHEMBL1200795
CLEMASTINE FUMARATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1.O=C(O)/C=C/C(=O)O
Basic Information
| ChEMBL ID | CHEMBL1200795 |
| Name | CLEMASTINE FUMARATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | PMGQWSIVQFOFOQ-YKVZVUFRSA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1626 |
| Active Moiety | CHEMBL1626 |
6
Targets
16
Activities
1
Assay Types
0
PK Parameters
20
Publications
6
Known Names
8
Indications
1
Mechanisms
Molecular Properties
343.9
MW (Da)
5.10
ALogP
2
HBA
0
HBD
12.5
PSA (Ų)
0.72
QED
1
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1977 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Histamine H1 receptor antagonist | ANTAGONIST | Histamine H1 receptor | ✓ | ✓ |
Indications
Common Cold Rhinitis, Allergic Rhinitis, Allergic, Seasonal Urticaria Hypersensitivity Multiple Sclerosis Multiple Sclerosis, Chronic Progressive Multiple Sclerosis, Relapsing-Remitting
Activity Summary
IC50 16 meas. best 6.34
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 6.34 | 5.5022 | 456.0 | 9 |
| Plasmodium berghei CHEMBL612653 | IC50 | 6.02 | 6.02 | 951.0 | 1 |
| SARS-CoV CHEMBL4303836 | IC50 | 5.94 | 5.94 | 1153.0 | 1 |
| Middle East respiratory syndrome-related coronavirus CHEMBL4296578 | IC50 | 5.87 | 5.87 | 1343.0 | 1 |
| Plasmodium CHEMBL4888483 | IC50 | 5.66 | 5.66 | 2200.0 | 1 |
| SARS-CoV-2 CHEMBL4303835 | IC50 | 5.65 | 5.2 | 2245.0 | 3 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | Fibroblast | 345 |
| - | 10.6019/CHEMBL4689842 | HEK-293T | 345 |
| - | 10.6019/CHEMBL4689842 | U2OS | 343 |
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| 34394844 | 10.1021/acsmedchemlett.1c00263 | SARS-CoV-2 | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 22586124 | 10.1073/pnas.1118370109 | Plasmodium falciparum | 2 |
| - | 10.6019/CHEMBL5209801 | G-protein coupled receptor 35 | 2 |
Data from ChEMBL 36 via Core Engine